Improving HIV testing and treatment for commercial minibus drivers
Official title: Innovative Tools to Expand HIV Self-Testing and Long-Acting Injectables for HIV Treatment and Prevention Among Commercial Minibus Drivers (I-TEST LAIs)
Funded at George Washington University · NIH-11009232 · Data updated 2026-11-12
This study is all about making it easier for commercial minibus drivers in Nigeria to get tested and treated for HIV, using private self-testing and long-lasting treatments, so they can stay healthy while managing their busy lives.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | George Washington University NIH-funded |
| Lab location | 1 site (Washington, United States) |
| Project start | August 15, 2024 |
| Project end | June 30, 2029 |
| Funding year | 2024 |
| Award (this year) | $809,692 |
| NIH project number | 1R01AI186786-01 |
| Project ID | NIH-11009232 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are commercial minibus drivers who are at risk for HIV or are living with HIV.
✕Less likely to help
Patients who are not involved in the commercial driving profession or those who are not at risk for HIV may not benefit from this research.
What this research studies
This research focuses on enhancing access to HIV testing and treatment for commercial minibus drivers, a group at high risk for HIV due to their mobile lifestyle. The project aims to implement innovative strategies such as HIV self-testing, which allows drivers to test privately, and long-acting injectables for HIV treatment and prevention. By addressing the barriers these drivers face in accessing healthcare, the research seeks to improve their health outcomes and adherence to treatment. The study will leverage previous successful interventions tailored for youth to create a specific program for this population in Nigeria.
Why it matters
Potential benefit: If successful, this research could significantly increase HIV testing rates and improve treatment adherence among commercial minibus drivers.
How similar studies have gone: Previous research has shown success with similar interventions aimed at increasing HIV testing and treatment adherence among high-risk populations.
Where this research is happening
-
George Washington University
Washington, United States Active
Researchers
- Principal investigator: Conserve, Donaldson — George Washington University
- Study coordinator: Conserve, Donaldson
Related research
Other NIH-funded projects on the same topics.
-
HLA-F and KIR3DS1: unlocking NK cell help to control HIV
A short, patient-friendly look at how a specific immune interaction might help the body control HIV and reduce long-term health problems.
-
Emerging therapies for rare maternal mitochondrial diseases with shared causes
A basket clinical trial will test new drug candidates for two ultra-rare mitochondrial diseases (MELAS and LHON-Plus) that share the same underlying energy-making problem in people who could be affected.
-
Anti-cancer vaccine for liver fluke infection and bile duct cancer
A vaccine approach aims to stop liver fluke interactions with the human bile ducts to prevent bile duct cancer in regions where the parasite is common.
-
Anti-cancer vaccine targeting the host-parasite interface during liver fluke infection
A vaccine approach aims to block how a liver fluke parasite communicates with the human liver to prevent bile duct cancer in people in Southeast Asia.
-
Understanding why youth develop type 2 diabetes and how to prevent it
A nationwide study aims to unravel why some teens with obesity develop type 2 diabetes while others don’t, and to identify factors that could help prevent it.
-
Ultrasensitive antibody-detection method to screen HIV-bNAbs
A new, ultra-sensitive test will help identify which broadly neutralizing antibodies can best block HIV-1 in people, by quickly checking how well these antibodies interact with the virus in patient-derived samples.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.